"At Ascension Via Christi Cancer Center in Wichita, Kansas on the Ascension Via Christi St. Francis campus, our doctors and nurses listen to understand your questions and concerns and provide answers to your questions. Then we deliver a care plan with cancer-fighting treatments and support programs. Our medical, radiation and surgical oncologists, oncology-certified nurses, palliative care specialists, genetic counselors, dietitians, and rehabilitation therapists focus on your needs. We’re dedicated to helping you defeat cancer."

During the past decade, Via Christi Cancer Center at Via Christi Regional Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 93 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Via Christi Cancer Center at Via Christi Regional Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 76 trials, followed by "SWOG Cancer Research Network" with 64 trials sponsored, "Eastern Cooperative Oncology Group" with 23 trials sponsored, "NSABP Foundation Inc" with 10 trials sponsored and "Children's Oncology Group" with 10 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Via Christi Cancer Center at Via Christi Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 194 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "Eastern Cooperative Oncology Group" with 8 trials as a collaborator and "North Central Cancer Treatment Group" with 6 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Via Christi Cancer Center at Via Christi Regional Medical Center" are "Breast Cancer" (42 trials), "Lung Cancer" (23 trials), "Lymphoma" (21 trials), "Leukemia" (20 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials). Many other conditions were trialed in "Via Christi Cancer Center at Via Christi Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Via Christi Cancer Center at Via Christi Regional Medical Center" are "Drug" (160 trials), "Biological" (63 trials), "Other" (51 trials), "Radiation" (39 trials) and "Procedure" (25 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (30 trials), "radiation therapy" (25 trials), "cyclophosphamide" (23 trials), "bevacizumab" (16 trials) and "paclitaxel" (15 trials). Other intervention names were less common.

The vast majority of trials in "Via Christi Cancer Center at Via Christi Regional Medical Center" are 156 trials for "All" genders, 33 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Via Christi Cancer Center at Via Christi Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 165 completed trials in Via Christi Cancer Center at Via Christi Regional Medical Center, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Via Christi Cancer Center at Via Christi Regional Medical Center, 8 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".